CSL Ltd. (CSLLY)
32.90
-0.57
(-1.70%)
USD |
OTCM |
Nov 18, 16:00
CSL Price : 32.90 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2026 | 32.56 | 33.38 | 32.56 | 32.90 | 796386.0 |
| Nov 17, 2026 | 33.57 | 33.70 | 33.35 | 33.47 | 46932.00 |
| Nov 16, 2026 | 33.28 | 34.31 | 33.28 | 34.00 | 42681.00 |
| Nov 13, 2026 | 34.60 | 34.60 | 34.32 | 34.41 | 35616.00 |
| Nov 12, 2026 | 34.72 | 34.81 | 34.61 | 34.67 | 38476.00 |
| Nov 11, 2026 | 34.26 | 34.62 | 34.26 | 34.61 | 34131.00 |
| Nov 10, 2026 | 34.33 | 34.52 | 34.09 | 34.45 | 32553.00 |
| Nov 09, 2026 | 34.70 | 35.20 | 34.68 | 35.15 | 55734.00 |
| Nov 06, 2026 | 36.06 | 36.06 | 33.36 | 34.76 | 54744.00 |
| Nov 05, 2026 | 36.88 | 36.88 | 34.77 | 34.96 | 63916.00 |
| Nov 04, 2026 | 33.89 | 35.10 | 33.89 | 35.10 | 32124.00 |
| Nov 03, 2026 | 35.21 | 35.21 | 34.60 | 34.64 | 40669.00 |
| Nov 02, 2026 | 35.50 | 35.50 | 35.26 | 35.35 | 25635.00 |
| Oct 30, 2026 | 35.48 | 35.48 | 35.22 | 35.39 | 26934.00 |
| Oct 29, 2026 | 34.81 | 35.00 | 34.68 | 35.00 | 43225.00 |
| Oct 28, 2026 | 35.26 | 35.60 | 34.66 | 34.76 | 43163.00 |
| Oct 27, 2026 | 34.58 | 34.64 | 34.45 | 34.64 | 39949.00 |
| Oct 26, 2026 | 34.15 | 34.26 | 34.07 | 34.16 | 63281.00 |
| Oct 23, 2026 | 35.14 | 35.14 | 34.29 | 34.60 | 27820.00 |
| Oct 22, 2026 | 34.04 | 34.53 | 34.04 | 34.40 | 41362.00 |
| Oct 21, 2026 | 35.00 | 35.19 | 34.26 | 34.28 | 51543.00 |
| Oct 20, 2026 | 35.64 | 35.64 | 34.00 | 34.49 | 55482.00 |
| Oct 19, 2026 | 33.55 | 33.81 | 33.55 | 33.60 | 38928.00 |
| Oct 16, 2026 | 33.35 | 33.48 | 33.22 | 33.35 | 36626.00 |
| Oct 15, 2026 | 31.11 | 32.60 | 31.11 | 32.60 | 94363.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Immutep Ltd. | 3.42 |
| Ceryvyn Therapeutics Ltd. | 0.028 |
| Propanc Biopharma, Inc. | 1.73 |
| Mesoblast Ltd. | 11.20 |
| Actinogen Medical Ltd. | 0.33 |
Price Related Metrics
| PS Ratio | 4.035 |
| Price to Free Cash Flow | 28.32 |
| Earnings Yield | -4.12% |
| Market Cap | 63.02B |
| Operating PE Ratio | 15.85 |
| Normalized PE Ratio | 22.14 |